Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpharmatimes.com
PharmaTimes: News RSS
Get the latest updates from PharmaTimes: News RSS directly as they happen.
Follow now 136 followers
Latest posts
Last updated 2 days ago
CERo reports encouraging early data from phase 1 trial of CER‑1236
2 days ago
CER‑T therapy shows initial safety signals and prompts protocol expansion
ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
2 days ago
Trial to assess whether once‑weekly treatment can reduce symptomatic viral respiratory infections
Argo Biopharma doses first patient in phase 2b trial of BW‑20829
3 days ago
siRNA therapeutic progresses in global study for patients with elevated Lp(a)
Akari files new patent and advances second ADC targeting CEACAM5
3 days ago
Company strengthens pipeline with AKTX-102 as it broadens its intellectual property estate
BioMed X launches kidney disease project in partnership with the government of Barbados
4 days ago
Initiative focuses on population-specific molecular profiling
Gedeon Richter UK takes over UK rights to cariprazine
4 days ago
Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati
Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
5 days ago
Dawnzera showed an 81% reduction in the four-weekly rate of HAE attacks...
Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
5 days ago
Ovarian cancer is the fifth leading cause of deaths from cancer in...
ErVimmune raises 17m euros in funding to develop cancer vaccine
9 days ago
The vaccine could be created as a ready-to-use product, rather than needing...
Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
9 days ago
The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications
Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
10 days ago
More than 71% of patients treated with Unloxcyt achieved disease control
Venner Shipley announces opening of new Bristol office
11 days ago
The firm already has a number of offices across the UK and...